HIGHVISTA STRATEGIES LLC Neurocrine Biosciences, Inc. Transaction History

HIGHVISTA STRATEGIES LLC portfolio value:

$889,000
portfolio value

HIGHVISTA STRATEGIES LLC quarter portfolio value change:

+8.96%
quarter

Neurocrine Biosciences, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +122.27% 4.60K shares 522K $106.21 8.37K
Q2 2022 share Increase 0.00% 3.76K shares 367K $97.48 3.76K
Q4 2021 share Decrease -100.00% -13.20K shares -1.26M $84.63 0
Q3 2021 share Increase +62.22% 5.06K shares 474K $95.91 13.20K
Q2 2021 share Increase 0.00% 8.14K shares 792K $97.32 8.14K